Xiaofei Ye
Impact in
- Toxicology top 0.2%
- Pharmacovigilance and Adverse Drug Reactions
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Toxicology 37
- Pharmacovigilance and Adverse Drug Reactions 37
- Epidemiology 28
- Acute Ischemic Stroke Management 21
- Co-authors
- Jia He (49 shared papers)Xiao-Jing Guo (30 shared papers)Jinfang Xu (24 shared papers)Qing-Bin Gao (10 shared papers)Yinghong Zhai (16 shared papers)Fangyuan Hu (15 shared papers)Yingyi Qin (5 shared papers)Junhong Bai (3 shared papers)
- Journals
- Pharmacoepidemiology and Drug Safety (6 papers)Expert Opinion on Drug Safety (6 papers)British Journal of Clinical Pharmacology (5 papers)Frontiers in Neurology (4 papers)Medicine (4 papers)
- Partner nations
- ChinaSwedenUnited States
In The Last Decade
Xiaofei Ye
165 papers receiving 4.2k citations
Peers
Comparison fields: 5 of 153
- Toxicology 452
- Hepatology 414
- Critical Care and Intensive Care Medicine 194
- Oncology 431
- Health, Toxicology and Mutagenesis 176
Countries citing papers authored by Xiaofei Ye
This map shows the geographic impact of Xiaofei Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofei Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofei Ye more than expected).
Fields of papers citing papers by Xiaofei Ye
This network shows the impact of papers produced by Xiaofei Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofei Ye. The network helps show where Xiaofei Ye may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaofei Ye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 179 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 225 | |
| 2 | 2019 | 187 | |
| 3 | 2017 | 184 | |
| 4 | 2017 | 161 | |
| 5 | 2014 | 155 | |
| 6 | 2019 | 152 | |
| 7 | 2019 | 128 | |
| 8 | 2013 | 125 | |
| 9 | 2010 | 117 | |
| 10 | 2016 | 114 | |
| 11 | 2018 | 101 | |
| 12 | 2020 | 90 | |
| 13 | 2015 | 89 | |
| 14 | 2020 | 88 | |
| 15 | 2017 | 79 | |
| 16 | 2023 | 75 | |
| 17 | 2013 | 69 | |
| 18 | 2021 | 66 | |
| 19 | 2018 | 63 | |
| 20 | 2012 | 61 |
About Xiaofei Ye
Xiaofei Ye is a scholar working on Toxicology, Epidemiology, Cardiology and Cardiovascular Medicine, Oncology and Endocrinology, Diabetes and Metabolism, having authored 179 papers that have together received 4.3k indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (37 papers), Acute Ischemic Stroke Management (21 papers), Blood Pressure and Hypertension Studies (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Atrial Fibrillation Management and Outcomes (6 papers), Lipoproteins and Cardiovascular Health (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Epilepsy research and treatment (5 papers). The work is most often cited by research in Toxicology (452 citations), Hepatology (414 citations), Critical Care and Intensive Care Medicine (194 citations), Oncology (431 citations) and Health, Toxicology and Mutagenesis (176 citations). Xiaofei Ye has collaborated with scholars based in China, Sweden and United States. Frequent co-authors include Jia He, Xiao-Jing Guo, Jinfang Xu, Qing-Bin Gao, Yinghong Zhai, Fangyuan Hu, Yingyi Qin, Junhong Bai, Qingqing Zhao and Wentao Shi. Their work appears in journals such as Pharmacoepidemiology and Drug Safety, Expert Opinion on Drug Safety, British Journal of Clinical Pharmacology, Frontiers in Neurology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.